Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 8

1.

Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients.

Weinstock-Guttman B, Zivadinov R, Qu J, Cookfair D, Duan X, Bang E, Bergsland N, Hussein S, Cherneva M, Willis L, Heininen-Brown M, Ramanathan M.

J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):189-95. doi: 10.1136/jnnp.2010.227942. Epub 2010 Nov 3.

PMID:
21047880
2.

Vitamin D metabolism and the clinical aspects of measuring metabolites.

Iqbal SJ.

Ann Clin Biochem. 1994 Mar;31 ( Pt 2):109-24. Review. No abstract available.

PMID:
8060088
3.

Vitamin D and multiple health outcomes in the Harvard cohorts.

Wei MY, Giovannucci EL.

Mol Nutr Food Res. 2010 Aug;54(8):1114-26. doi: 10.1002/mnfr.200900574. Review.

PMID:
20486209
4.

[Diagnostic value of determining the levels of 25-hydroxyvitamin D 3, 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D 3 in kidney diseases].

Kokot F, Wiecek A, Drab M.

Pol Tyg Lek. 1992 Aug 7-17;47(31-33):703-5. Review. Polish. No abstract available.

PMID:
1492043
5.

Measurement of vitamin D and its metabolites (calcidiol and calcitriol) and their clinical significance.

Schmidt-Gayk H, Bouillon R, Roth HJ.

Scand J Clin Lab Invest Suppl. 1997;227:35-45. Review.

PMID:
9127467
6.

Diffusion tensor MRI in multiple sclerosis.

Rovaris M, Filippi M.

J Neuroimaging. 2007 Apr;17 Suppl 1:27S-30S. Review.

PMID:
17425731
7.

Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes.

Hollis BW, Wagner CL.

J Clin Endocrinol Metab. 2013 Dec;98(12):4619-28. doi: 10.1210/jc.2013-2653. Epub 2013 Oct 8. Review.

8.

[Vitamin D metabolites].

Okazaki R, Tanaka K.

Nihon Rinsho. 1999 Sep;57 Suppl:150-3. Review. Japanese. No abstract available.

PMID:
10543074
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk